130 related articles for article (PubMed ID: 27559686)
1. Serum Phosphate and Creatinine Levels in the First Year of Life in Infants Born to HIV-Positive Mothers Receiving Tenofovir-Based Combination Regimens During Pregnancy and Prolonged Breastfeeding in an Option B+ Program in Malawi.
Floridia M; Liotta G; Andreotti M; Galluzzo CM; Jere H; Sagno JB; Mancinelli S; Amici R; Marazzi MC; Vella S; Giuliano M; Palombi L
J Acquir Immune Defic Syndr; 2016 Dec; 73(5):e90-e91. PubMed ID: 27559686
[No Abstract] [Full Text] [Related]
2. Levels of bone markers in a population of infants exposed in utero and during breastfeeding to tenofovir within an Option B+ programme in Malawi.
Floridia M; Liotta G; Andreotti M; Galluzzo CM; Amici R; Jere H; Sagno JB; Marazzi MC; Buonomo E; Scarcella P; Mancinelli S; Vella S; Giuliano M; Palombi L
J Antimicrob Chemother; 2016 Nov; 71(11):3206-3211. PubMed ID: 27494909
[TBL] [Abstract][Full Text] [Related]
3. Growth and Neurodevelopment Outcomes in HIV-, Tenofovir-, and Efavirenz-Exposed Breastfed Infants in the PMTCT Option B+ Program in Malawi.
Kapito-Tembo AP; Bauleni A; Wesevich A; Ongubo D; Hosseinipour MC; Dube Q; Mwale P; Corbett A; Mwapasa V; Phiri S
J Acquir Immune Defic Syndr; 2021 Jan; 86(1):81-90. PubMed ID: 33027153
[TBL] [Abstract][Full Text] [Related]
4. Safety and efficacy of Option B+ ART in Malawi: few severe maternal toxicity events or infant HIV infections among pregnant women initiating tenofovir/lamivudine/efavirenz.
Harrington BJ; DiPrete BL; Jumbe AN; Ngongondo M; Limarzi L; Wallie SD; Chagomerana MB; Hosseinipour MC;
Trop Med Int Health; 2019 Oct; 24(10):1221-1228. PubMed ID: 31381233
[TBL] [Abstract][Full Text] [Related]
5. HIV transmission and retention in care among HIV-exposed children enrolled in Malawi's prevention of mother-to-child transmission programme.
Haas AD; van Oosterhout JJ; Tenthani L; Jahn A; Zwahlen M; Msukwa MT; Davies MA; Tal K; Phiri N; Spoerri A; Chimbwandira F; Egger M; Keiser O
J Int AIDS Soc; 2017 Sep; 20(1):21947. PubMed ID: 28884524
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and outcomes of women initiating ART during pregnancy versus breastfeeding in Option B+ in Malawi.
Landes M; Sodhi S; Matengeni A; Meaney C; van Lettow M; Chan AK; van Oosterhout JJ
BMC Public Health; 2016 Aug; 15():713. PubMed ID: 27487775
[TBL] [Abstract][Full Text] [Related]
7. Rapid Antiretroviral Therapy Initiation for Women in an HIV-1 Prevention Clinical Trial Experiencing Primary HIV-1 Infection during Pregnancy or Breastfeeding.
Morrison S; John-Stewart G; Egessa JJ; Mubezi S; Kusemererwa S; Bii DK; Bulya N; Mugume F; Campbell JD; Wangisi J; Bukusi EA; Celum C; Baeten JM;
PLoS One; 2015; 10(10):e0140773. PubMed ID: 26469986
[TBL] [Abstract][Full Text] [Related]
8. Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV.
Palombi L; Marazzi MC; Voetberg A; Magid NA
AIDS; 2007 Jul; 21 Suppl 4():S65-71. PubMed ID: 17620755
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of WHO recommendation for continued breastfeeding and maternal cART for prevention of perinatal and postnatal HIV transmission in Zambia.
Ngoma MS; Misir A; Mutale W; Rampakakis E; Sampalis JS; Elong A; Chisele S; Mwale A; Mwansa JK; Mumba S; Chandwe M; Pilon R; Sandstrom P; Wu S; Yee K; Silverman MS
J Int AIDS Soc; 2015; 18(1):19352. PubMed ID: 26140453
[TBL] [Abstract][Full Text] [Related]
10. Comparative cost-effectiveness of Option B+ for prevention of mother-to-child transmission of HIV in Malawi.
Tweya H; Keiser O; Haas AD; Tenthani L; Phiri S; Egger M; Estill J
AIDS; 2016 Mar; 30(6):953-62. PubMed ID: 26691682
[TBL] [Abstract][Full Text] [Related]
11. Concentrations of tenofovir, lamivudine and efavirenz in mothers and children enrolled under the Option B-Plus approach in Malawi.
Palombi L; Pirillo MF; Marchei E; Jere H; Sagno JB; Luhanga R; Floridia M; Andreotti M; Galluzzo CM; Pichini S; Mwenda R; Mancinelli S; Marazzi MC; Vella S; Liotta G; Giuliano M
J Antimicrob Chemother; 2016 Apr; 71(4):1027-30. PubMed ID: 26679247
[TBL] [Abstract][Full Text] [Related]
12. Antibodies against pneumococcal capsular polysaccharide in Malawian HIV-positive mothers and their HIV-exposed uninfected children.
Baroncelli S; Galluzzo CM; Mancinelli S; Andreotti M; Jere H; Amici R; Marazzi MC; Vella S; Palombi L; Giuliano M
Infect Dis (Lond); 2016 Apr; 48(4):317-321. PubMed ID: 26609569
[TBL] [Abstract][Full Text] [Related]
13. HIV-positive pregnant and postpartum women's perspectives about Option B+ in Malawi: a qualitative study.
Katirayi L; Namadingo H; Phiri M; Bobrow EA; Ahimbisibwe A; Berhan AY; Buono N; Moland KM; Tylleskär T
J Int AIDS Soc; 2016; 19(1):20919. PubMed ID: 27312984
[TBL] [Abstract][Full Text] [Related]
14. Assessing Option B+ retention and infant follow-up in Lilongwe, Malawi.
Hauser BM; Miller WC; Tweya H; Speight C; Mtande T; Phiri S; Ball LM; Hosseinipour MC; Hoffman IF; Rosenberg NE
Int J STD AIDS; 2018 Feb; 29(2):185-194. PubMed ID: 28750577
[TBL] [Abstract][Full Text] [Related]
15. Growth indices in breastfed infants pre and postnatally exposed to tenofovir compared with tenofovir-unexposed infants.
Liotta G; Floridia M; Andreotti M; Jere H; Sagno JB; Marazzi MC; Buonomo E; Scarcella P; Mancinelli S; Vella S; Giuliano M; Palombi L
AIDS; 2016 Jan; 30(3):525-7. PubMed ID: 26765942
[TBL] [Abstract][Full Text] [Related]
16. Prevention of TB using rifampicin plus isoniazid reduces nevirapine concentrations in HIV-exposed infants.
McIlleron H; Denti P; Cohn S; Mashabela F; Hoffmann JD; Shembe S; Msandiwa R; Wiesner L; Velaphi S; Lala SG; Chaisson RE; Martinson N; Dooley KE;
J Antimicrob Chemother; 2017 Jul; 72(7):2028-2034. PubMed ID: 28419277
[TBL] [Abstract][Full Text] [Related]
17. Viral Suppression and HIV Drug Resistance at 6 Months Among Women in Malawi's Option B+ Program: Results From the PURE Malawi Study.
Hosseinipour M; Nelson JAE; Trapence C; Rutstein SE; Kasende F; Kayoyo V; Kaunda-Khangamwa B; Compliment K; Stanley C; Cataldo F; van Lettow M; Rosenberg NE; Tweya H; Gugsa S; Sampathkumar V; Schouten E; Eliya M; Chimbwandira F; Chiwaula L; Kapito-Tembo A; Phiri S;
J Acquir Immune Defic Syndr; 2017 Jun; 75 Suppl 2(Suppl 2):S149-S155. PubMed ID: 28498184
[TBL] [Abstract][Full Text] [Related]
18. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
19. Maternal Highly Active Antiretroviral Therapy and Child HIV-Free Survival in Malawi, 2004-2009.
Schwartz SR; Kumwenda N; Kumwenda J; Chen S; Mofenson LM; Taylor AW; Fowler MG; Taha TE
Matern Child Health J; 2016 Mar; 20(3):542-9. PubMed ID: 26525557
[TBL] [Abstract][Full Text] [Related]
20. Involving both parents in HIV prevention during pregnancy and breastfeeding.
Chi BH; Rosenberg NE; Mweemba O; Powers KA; Zimba C; Maman S; Kasaro M; Mollan KR; Stringer JS; Mutale W
Bull World Health Organ; 2018 Jan; 96(1):69-71. PubMed ID: 29403103
[No Abstract] [Full Text] [Related]
[Next] [New Search]
